DISC MEDICINE INC(NASDAQ:IRON) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to IRON. IRON was compared to 572 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for IRON as it has an excellent financial health rating, but there are worries on the profitability. IRON does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IRON has reported negative net income.

IRON had a negative operating cash flow in the past year.

In the past 5 years IRON always reported negative net income.

In the past 5 years IRON always reported negative operating cash flow.

1.2 Ratios

IRON has a Return On Assets of -20.90%. This is in the better half of the industry: IRON outperforms 76.91% of its industry peers.

IRON has a better Return On Equity (-22.11%) than 84.01% of its industry peers.

		Industry Rank	Sector Rank
ROA	-20.9%
ROE	-22.11%
ROIC	N/A

ROA(3y)-31.78%

ROA(5y)N/A

ROE(3y)-35.42%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IRON does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, IRON has about the same amount of shares outstanding.

There is no outstanding debt for IRON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

IRON has an Altman-Z score of 40.66. This indicates that IRON is financially healthy and has little risk of bankruptcy at the moment.

IRON has a Altman-Z score of 40.66. This is amongst the best in the industry. IRON outperforms 97.34% of its industry peers.

There is no outstanding debt for IRON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	40.66

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

IRON has a Current Ratio of 19.36. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.

IRON's Current ratio of 19.36 is amongst the best of the industry. IRON outperforms 94.49% of its industry peers.

IRON has a Quick Ratio of 19.36. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of IRON (19.36) is better than 94.49% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	19.36
Quick Ratio	19.36

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IRON shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.55%.

EPS 1Y (TTM)-4.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-53.45%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 8.32% on average over the next years. This is quite good.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-23.39%

EPS Next 2Y-22.3%

EPS Next 3Y-14.26%

EPS Next 5Y8.32%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IRON. In the last year negative earnings were reported.

Also next year IRON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as IRON's earnings are expected to decrease with -14.26% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-22.3%

EPS Next 3Y-14.26%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

IRON does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DISC MEDICINE INC

NASDAQ:IRON (2/21/2025, 8:00:02 PM)

After market: 54.53 0 (0%)

54.53

+0.18 (+0.33%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)11-12 2024-11-12/bmo

Earnings (Next)03-19 2025-03-19/amc

Inst Owners67.45%

Inst Owner Change-1.98%

Ins Owners1.13%

Ins Owner Change3.5%

Market Cap1.87B

Analysts85.88

Price Target96.71 (77.35%)

Short Float %8.31%

Short Ratio6.45

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)13.14%

Min EPS beat(2)9.14%

Max EPS beat(2)17.14%

EPS beat(4)2

Avg EPS beat(4)1.47%

Min EPS beat(4)-13.49%

Max EPS beat(4)17.14%

EPS beat(8)4

Avg EPS beat(8)-10%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)1.36%

PT rev (3m)44.26%

EPS NQ rev (1m)-3.29%

EPS NQ rev (3m)25.14%

EPS NY rev (1m)-0.44%

EPS NY rev (3m)6.81%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	3.99
P/tB	3.99
EV/EBITDA	N/A

EPS(TTM)-3.91

EYN/A

EPS(NY)-5.12

Fwd EYN/A

FCF(TTM)-2.46

FCFYN/A

OCF(TTM)-2.45

OCFYN/A

SpS0

BVpS13.65

TBVpS13.65

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-20.9%
ROE	-22.11%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-31.78%

ROA(5y)N/A

ROE(3y)-35.42%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	32.93%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	19.36
Quick Ratio	19.36
Altman-Z	40.66

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)95.37%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-4.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-53.45%

EPS Next Y-23.39%

EPS Next 2Y-22.3%

EPS Next 3Y-14.26%

EPS Next 5Y8.32%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-50.92%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-59.15%

EBIT Next 3Y-16.18%

EBIT Next 5YN/A

FCF growth 1Y-97.98%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-97.9%

OCF growth 3YN/A

OCF growth 5YN/A

DISC MEDICINE INC (IRON) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens